Old Web
English
Sign In
Acemap
>
Paper
>
Effects of simufilam on cerebrospinal fluid biomarkers in Alzheimer’s disease: A randomized clinical trial
Effects of simufilam on cerebrospinal fluid biomarkers in Alzheimer’s disease: A randomized clinical trial
2021
Hoau-Yan Wang
Zhe Pei
Kuo-Chieh Lee
Yaneicy Gonzalez-Rojas
Tamara Doehner
John Puente
Patrick Sciara
Brian Beck
Evelyn Lopez-Brignoni
Boris Nikolov
Carrie Crowley
George Ben Thornton
Rémi Barbier
Nadav Friedmann
Jeffrey L. Cummings
Lindsay H. Burns
Keywords:
Biomarker (medicine)
Disease
Internal medicine
Cerebrospinal fluid
Randomized controlled trial
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]